Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

BINGO for better health: fun games aim to boost cancer awareness in black communities

NCT ID NCT06504407

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether playing educational BINGO games could help Black adults learn about cancer and clinical trials. 54 participants played BINGO in a relaxed setting and answered surveys to measure their knowledge and engagement. The goal was to build trust and find better ways to include diverse groups in future cancer research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Oct 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age: Adults aged 18 years and above. 2. Gender Identity: Individuals identifying as cisgender, transgender, or females. 3. Language Proficiency: Proficiency in English equivalent to middle school/high school level. 4. Registration: Completion of registration via the provided RedCap link prior to the Bingo session. 5. Consent: Willingness to provide written consent at the beginning of the Bingo session to participate in the research study. Exclusion Criteria: 1. Age: Individuals under the age of 18 years. 2. Gender Identity: Participants who do not identify as cisgender, transgender, or females. 3. Language Proficiency: Inability to understand English at a middle school/high school level. 4. Previous Participation: Individuals who have already participated in a previous Bingo game session for this study. 5. Medical or Cognitive Impairment: Participants unable to provide informed consent or actively participate due to medical or cognitive reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer education are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Penn State Cancer Institute

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.